J&J expects to deliver 20M COVID-19 vaccine doses before April if authorized
Johnson & Johnson plans to deliver 20 million doses of its COVID-19 vaccine candidate to the United States by the end of March if the Food and Drug Administration authorizes emergency use of the single-dose vaccine, a company executive told a House subcommittee today at a on expanding vaccine availability.
An FDA advisory committee expects Friday to consider the emergency use application. If authorized for emergency use, the J&J candidate would be the third COVID-19 vaccine authorized for use in the United States, joining the Pfizer and Moderna vaccines. The departments of Health and Human Services and Defense in August 100 million doses of the J&J vaccine candidate and could acquire up to 300 million additional doses under the agreement.